Let's hope he is right! Steve Rosenman......Although IMS is reporting scripts data for Vascepa that is higher than Lovaza launch, it seems investors are not pleased. But, are they reading that data right? The answer is not at all. If you are assuming that AMRN only has the scripts reported by IMS, you are not paying attention to what is going on. Amarin has a free drug program going on that to my estimates is pulling 3X more patients in than IMS is reporting. Free scripts don't get reported. You will eventually see these come on board as paid prescriptions down the line, but to ignore the promotional strategy would be a mistake. It's likely scripts are over 4-5K / week already, but AMRN will not offer any PR..And they shouldn't. Why let a competitor know what's going on.
When I received my free Vascepa..it came with a prescription..you go to the pharmacy and give them a card and the first month deductible is free to you but the rest is paid by the insurance company. So my opinion is yes they are counted.
I requested info from Amarin regarding whether the 30 day free supply is counted through IMS but as I have discovered they do not respond to shareholder inquiries. My question though is this.......The "free" scripts actually are paid scripts....since Amarin does pay for those 30 day "free" scripts how is it they could be considered unpaid scripts?
Agreed, Amarin management has always ignored the status quo. Some say they are arrogant. So it's no wonder the market under appreciates their numbers. If it doubles in a year I am extaatic. Let the day traders cry over daily moves.
Rosenman has proven that he is capable of spouting off whatever he wishes without ever worrying about whether he is correct or incorrect.
Someone posed a question, among many questions, to him on SA as to whether his close proximity to Amarin's NJ headquarters was coincidence or if there was a "connection". SR never answered. His silence spoke volumes.
SR takes on this superiority stance for whatever reason. Whether he is misleading people purposely or unintentionally is undetermined at this point. But based on actual results when compared to his predictions, it is clear that he is not as all-knowing as he pretends to be.
1000 Doc's got 5 bottles so at least 5000 patients were, will be, started on Vascepa. Each bottle has 120 or a months supply. Patients get Vascepa directly from Doc, no Pharmacy involved on sample bottle. Now I would guess Doc's gave Rx to patients at time but most patients will try Vascepa sample for a month before filling Rx.
Sentiment: Strong Buy
I am certain you are wrong on that. Patients must go to the pharmacy to pick up the free 30 day supply. They must hand the pharmacist the coupon for the FREE 30 DAY but must also have a script in hand as well or the pharmacist cannot dispense it. in reality the 30 day supply is not free because Amarin does reimburse the pharmacy for the 30 day script.
If he's right on the number of freebies given out (2500-3500), then there is no way it's reported to IMS if the script number is currently at around 1400-1500. It would obviously have to be greater than 2500 and that's with zero paid scripts.... again, IF Steve's freebie numbers are accurate or even close to it.
Sentiment: Strong Buy